A meta-analysis suggests that high doses of psilocybin may alleviate depressive symptoms similarly to the SSRI drug escitalopram. While the effect size was small, psilocybin outperformed placebo in clinical trials, though study design flaws could have led to overestimated results. The findings indicate that psilocybin, particularly in high doses, may offer a new avenue for treating depression, comparable to existing antidepressants.

A new suggests that three-minute resistance exercise breaks every 30 minutes in the evening can extend sleep duration by an average of 27 minutes. This practice doesn't disrupt sleep quality and could reduce cardiometabolic disease risk. Participants engaged in simple exercises like chair squats and calf raises. Further research is needed to confirm these findings in real-life settings.